• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌病理分期的进展:区域和全身隐匿性转移的检测

Advances in the pathologic staging of lung cancer: detection of regional and systemic occult metastases.

作者信息

Chaiwun B, Saad A, Chatterjee S J, Taylor C R, Beattie E J, Cote R J

机构信息

Department of Pathology, University of Southern California, School of Medicine/Kenneth Norris Comprehensive Cancer Center, Los Angeles 90033, USA.

出版信息

Pathology (Phila). 1996;4(1):155-68.

PMID:8953619
Abstract

Approximately 78% of lung carcinomas would be potentially curable by surgery if they were detected early enough. Thus, the most important factor in predicting outcome and defining therapy is the stage of the disease. This chapter discusses the TNM (primary tumor/nodal involvement/distant metastasis) staging system for lung cancer as well as lymph node and bone marrow micrometastasis status.

摘要

如果能早期发现,大约78%的肺癌有可能通过手术治愈。因此,预测预后和确定治疗方案的最重要因素是疾病的分期。本章讨论肺癌的TNM(原发肿瘤/淋巴结受累/远处转移)分期系统以及淋巴结和骨髓微转移状态。

相似文献

1
Advances in the pathologic staging of lung cancer: detection of regional and systemic occult metastases.肺癌病理分期的进展:区域和全身隐匿性转移的检测
Pathology (Phila). 1996;4(1):155-68.
2
[Clinicopathological study on nodal molecular staging of non-small-cell lung cancer].非小细胞肺癌淋巴结分子分期的临床病理研究
Zhonghua Yi Xue Za Zhi. 2007 Jan 16;87(3):161-4.
3
Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.前哨淋巴结活检在实体肿瘤分期及治疗中的临床应用
Minerva Chir. 2005 Aug;60(4):217-33.
4
Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival.临床T1N0期肺癌隐匿性淋巴结转移的危险因素:对生存的负面影响。
Eur J Cardiothorac Surg. 2008 Mar;33(3):466-9. doi: 10.1016/j.ejcts.2007.12.015. Epub 2008 Jan 31.
5
Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.病理性N1期非小细胞肺癌:淋巴转移模式与预后的相关性
J Thorac Cardiovasc Surg. 2003 Mar;125(3):543-53. doi: 10.1067/mtc.2003.322.
6
An update on lung cancer staging.肺癌分期的最新进展。
Adv Anat Pathol. 2010 Jan;17(1):33-7. doi: 10.1097/PAP.0b013e3181c66f15.
7
Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.前哨淋巴结作为乳腺癌患者治疗规划的新标志物。
J Surg Oncol. 2004 Mar;85(3):102-11. doi: 10.1002/jso.20022.
8
New fields of application of the sentinel lymph node biopsy in the pathologic staging of solid neoplasms: review of literature and surgical perspectives.前哨淋巴结活检在实体肿瘤病理分期中的新应用领域:文献综述与手术展望
J Surg Oncol. 2004 Mar;85(3):171-9. doi: 10.1002/jso.20031.
9
Immunohistochemical detection of occult lymph node metastases in non-small cell lung cancer: anatomical pathology results from Cancer and Leukemia Group B Trial 9761.非小细胞肺癌隐匿性淋巴结转移的免疫组织化学检测:癌症与白血病B组试验9761的解剖病理学结果
Clin Cancer Res. 2003 Nov 15;9(15):5630-5.
10
Prognostic value of sentinel lymph node biopsy in the pathologic staging of colorectal cancer patients.前哨淋巴结活检在结直肠癌患者病理分期中的预后价值。
J Surg Oncol. 2004 Mar;85(3):166-70. doi: 10.1002/jso.20030.

引用本文的文献

1
Effectiveness of vitamin A acetate for enhancing the production of lung cancer specific monoclonal antibodies.醋酸视黄酯增强肺癌特异性单克隆抗体产生的效果。
Cytotechnology. 1999 Sep;31(1-2):77-83. doi: 10.1023/A:1008016020785.